2'3'-didehydro-2'3'-dideoxyadenosine and alanine

2'3'-didehydro-2'3'-dideoxyadenosine has been researched along with alanine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aquaro, S; Balzarini, J; De Clercq, E; Heijtink, R; Kruining, J; McGuigan, C; Naesens, L; Pannecouque, C; Perno, CF; Wedgwood, O; Witvrouw, M	1

Other Studies

1 other study(ies) available for 2'3'-didehydro-2'3'-dideoxyadenosine and alanine

Article	Year
Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus. FEBS letters, 1997, Jun-30, Volume: 410, Issue:2-3 Topics: Adenosine Monophosphate; Alanine; Animals; Anti-HIV Agents; Antiviral Agents; Cell Line; Cells, Cultured; Dideoxyadenosine; Hepatitis B virus; HIV; Humans; Leukocytes, Mononuclear; Macrophages; Molecular Structure; Moloney murine sarcoma virus; Simian Immunodeficiency Virus; Transfection; Tumor Cells, Cultured	1997

Article

Year

Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus.

FEBS letters, 1997, Jun-30, Volume: 410, Issue:2-3

Topics: Adenosine Monophosphate; Alanine; Animals; Anti-HIV Agents; Antiviral Agents; Cell Line; Cells, Cultured; Dideoxyadenosine; Hepatitis B virus; HIV; Humans; Leukocytes, Mononuclear; Macrophages; Molecular Structure; Moloney murine sarcoma virus; Simian Immunodeficiency Virus; Transfection; Tumor Cells, Cultured

1997